How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/hypocalcemia-from-end-stage-renal-disease-with-dialysis.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Hypocalcemia from End-Stage Renal Disease with Dialysis — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Hypocalcemia from End-Stage Renal Disease with Dialysis (disease) competitive landscape: 2 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

2 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Hypocalcemia from End-Stage Renal Disease with Dialysis, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	Line of therapy	First approval
Calcijex	CALCITRIOL	Esjay Pharma	Vitamin D3 Analog [EPC]	Vitamin D3 receptor		1978-01-01
Rocaltrol	Rocaltrol	Shandong University		Vitamin D 25-hydroxylase, 25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial, Vitamin D-binding protein

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Esjay Pharma · 1 drug in Hypocalcemia from End-Stage Renal Disease with Dialysis
Shandong University · 1 drug in Hypocalcemia from End-Stage Renal Disease with Dialysis

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Hypocalcemia from End-Stage Renal Disease with Dialysis:

Cite this brief

Drug Landscape (2026). Hypocalcemia from End-Stage Renal Disease with Dialysis — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/hypocalcemia-from-end-stage-renal-disease-with-dialysis. Accessed 2026-06-10.

Hypocalcemia from End-Stage Renal Disease with Dialysis full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing